Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03578783 · ClinicalTrials.gov registry record · Phase 2
PSD502 in Subjects With Premature Ejaculation
A Phase 2 study, sponsored by Plethora Solutions.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
NCT03578783: Completed Phase 2 study, sponsored by Plethora Solutions.
NCT03578783 is a Phase 2 study that has completed, run by Plethora Solutions. The registered enrollment target is 121 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03578783, a Phase 2 study, has completed, sponsored by Plethora Solutions.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
Study Summary
This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of the subjects will receive PSD502 and half will receive placebo.
Interventions
- DRUG Placebo
- DRUG PSD502
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2018-12-26 |
| Est. Completion | 2021-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03578783
The ClinicalTrials.gov registry entry for NCT03578783 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Plethora Solutions, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03578783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03578783 about?
NCT03578783 is a clinical study titled "PSD502 in Subjects With Premature Ejaculation". This study is being done to test the effect of PSD502 (the study medication) compared to placebo in subjects with premature ejaculation. PSD502 is a topical (applied to skin) anesthetic spray containing a mixture of two drugs called lidocaine and prilocaine that will be applied to the penis. Half of...
What is the current status of trial NCT03578783?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2018-12-26. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03578783?
The interventions under investigation include: Placebo (DRUG), PSD502 (DRUG).
Who is sponsoring clinical trial NCT03578783?
This trial is sponsored by Plethora Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.